Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 11
Submit an article Journal homepage
317
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Nucleophosmin gene-based monitoring in de novo cytogenetically normal acute myeloid leukemia with nucleophosmin gene mutations: comparison with cytofluorimetric analysis and study of Wilms tumor gene 1 expression

Maurizio MiglinoDepartment of Hematology and Oncology, IRCCS Azienda Ospedaliera Universitaria S. Martino-IST, Genova, ItalyCorrespondence[email protected]
,
Nicoletta ColomboDepartment of Hematology and Oncology, IRCCS Azienda Ospedaliera Universitaria S. Martino-IST, Genova, Italy
,
Raffaella GrassoDepartment of Hematology and Oncology, IRCCS Azienda Ospedaliera Universitaria S. Martino-IST, Genova, Italy
,
Carlo MaraniDepartment of Hematology and Oncology, IRCCS Azienda Ospedaliera Universitaria S. Martino-IST, Genova, Italy
,
Marino ClavioDepartment of Hematology and Oncology, IRCCS Azienda Ospedaliera Universitaria S. Martino-IST, Genova, Italy
,
Gian Matteo PicaDepartment of Hematology and Oncology, IRCCS Azienda Ospedaliera Universitaria S. Martino-IST, Genova, Italy
,
Filippo BalleriniDepartment of Hematology and Oncology, IRCCS Azienda Ospedaliera Universitaria S. Martino-IST, Genova, Italy
,
Chiara GhiggiDepartment of Hematology and Oncology, IRCCS Azienda Ospedaliera Universitaria S. Martino-IST, Genova, Italy
,
Paola MinettoDepartment of Hematology and Oncology, IRCCS Azienda Ospedaliera Universitaria S. Martino-IST, Genova, Italy
,
Fabio GuoloDepartment of Hematology and Oncology, IRCCS Azienda Ospedaliera Universitaria S. Martino-IST, Genova, Italy
,
Angelo Michele CarellaDepartment of Hematology and Oncology, IRCCS Azienda Ospedaliera Universitaria S. Martino-IST, Genova, Italy
&
Marco GobbiDepartment of Hematology and Oncology, IRCCS Azienda Ospedaliera Universitaria S. Martino-IST, Genova, Italy
 show all
Pages 2214-2217 | Received 09 Feb 2012, Accepted 26 Mar 2012, Published online: 21 May 2012

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Fabio Guolo, Paola Minetto, Marino Clavio, Riccardo Marcolin, Maurizio Miglino, Monica Passannante, Fabrizio Caviglia, Filippo Ballerini, Elisabetta Tedone, Annalisa Kunkl, Rosa Mangerini, Paola Contini, Nicoletta Colombo, Antonia Cagnetta, Michele Cea, Enrico Carminati, Girolamo Pugliese, Marco Gobbi & Roberto Massimo Lemoli. (2020) Prognostic relevance of a blastic plasmacytoid dendritic cell neoplasm-like immunophenotype in cytogenetically normal acute myeloid leukemia patients. Leukemia & Lymphoma 61:7, pages 1695-1701.
Read now

Articles from other publishers (8)

Fabio Guolo, Carmen Di Grazia, Paola Minetto, Anna Maria Raiola, Marino Clavio, Maurizio Miglino, Elisabetta Tedone, Paola Contini, Rosa Mangerini, Annalisa Kunkl, Nicoletta Colombo, Girolamo Pugliese, Enrico Carminati, Riccardo Marcolin, Monica Passannante, Samuele Bagnasco, Federica Galaverna, Teresa Lamparelli, Filippo Ballerini, Antonia Cagnetta, Michele Cea, Marco Gobbi, Andrea Bacigalupo, Roberto Massimo Lemoli & Emanuele Angelucci. (2021) Pre‐transplant minimal residual disease assessment and transplant‐related factors predict the outcome of acute myeloid leukemia patients undergoing allogeneic stem cell transplantation. European Journal of Haematology 107:5, pages 573-582.
Crossref
Paola Minetto, Anna Candoni, Fabio Guolo, Marino Clavio, Maria Elena Zannier, Maurizio Miglino, Maria Vittoria Dubbini, Enrico Carminati, Anna Sicuranza, Sara Ciofini, Nicoletta Colombo, Girolamo Pugliese, Riccardo Marcolin, Adele Santoni, Filippo Ballerini, Luca Lanino, Michele Cea, Marco Gobbi, Monica Bocchia, Renato Fanin & Roberto Massimo Lemoli. (2020) Fludarabine, High-Dose Cytarabine and Idarubicin-Based Induction May Overcome the Negative Prognostic Impact of FLT3-ITD in NPM1 Mutated AML, Irrespectively of FLT3-ITD Allelic Burden. Cancers 13:1, pages 34.
Crossref
Fabio Guolo, Paola Minetto, Marino Clavio, Maurizio Miglino, Nicoletta Colombo, Antonia Cagnetta, Michele Cea, Riccardo Marcolin, Andrea Todiere, Filippo Ballerini, Marco Gobbi & Roberto Massimo Lemoli. (2019) Longitudinal minimal residual disease (MRD) evaluation in acute myeloid leukaemia with NPM1 mutation: from definition of molecular relapse to MRD‐driven salvage approach . British Journal of Haematology 186:6.
Crossref
Jia Chen, Lingyi Yang, Yi Fan, Yang Xu, Yue Han, Xiaowen Tang, Huiying Qiu, Chengcheng Fu, Miao Miao, Feng Chen & Depei Wu. (2018) Comparison of Autologous Stem Cell Transplantation versus Haploidentical Donor Stem Cell Transplantation for Favorable- and Intermediate-Risk Acute Myeloid Leukemia Patients in First Complete Remission. Biology of Blood and Marrow Transplantation 24:4, pages 779-788.
Crossref
Fabio Guolo, Paola Minetto, Marino Clavio, Maurizio Miglino, Carmen Di Grazia, Filippo Ballerini, Giordana Pastori, Daniela Guardo, Nicoletta Colombo, Annalisa Kunkl, Giuseppina Fugazza, Barbara Rebesco, Mario Sessarego, Roberto Massimo Lemoli, Andrea Bacigalupo & Marco Gobbi. (2016) High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients. American Journal of Hematology 91:8, pages 755-762.
Crossref
Carlo Marani, Marino Clavio, Raffaella Grasso, Nicoletta Colombo, Fabio Guolo, Annalisa Kunkl, Filippo Ballerini, Livia Giannoni, Chiara Ghiggi, Giuseppina Fugazza, Jean-Louis Ravetti, Marco Gobbi & Maurizio Miglino. (2013) Integrating post induction WT1 quantification and flow-cytometry results improves minimal residual disease stratification in acute myeloid leukemia. Leukemia Research 37:12, pages 1606-1611.
Crossref
Christopher S. Hourigan & Judith E. Karp. (2013) Minimal residual disease in acute myeloid leukaemia. Nature Reviews Clinical Oncology 10:8, pages 460-471.
Crossref
Elaine Coustan-Smith & Dario Campana. (2013) Should evaluation for minimal residual disease be routine in acute myeloid leukemia?. Current Opinion in Hematology 20:2, pages 86-92.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.